Nonalcoholic Fatty Liver Disease (NAFLD)
Showing 1 - 25 of >10,000
Nonalcoholic Steatohepatitis, Genetic Risk Factor Trial (ALN-PNP Dose Level 1, ALN-PNP Dose Level 2, ALN-PNP Dose Level 3)
Not yet recruiting
- Nonalcoholic Steatohepatitis
- Genetic Risk Factor
- ALN-PNP Dose Level 1
- +3 more
- (no location specified)
Sep 5, 2023
Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)
Enrolling by invitation
- Nonalcoholic Fatty Liver Disease
-
Nashville, TennesseeVanderbilt University Medical Center
Jul 5, 2022
PCOS, NAFLD, NASH Trial in San Francisco, Durham
Recruiting
- PCOS
- +2 more
-
San Francisco, California
- +1 more
Nov 3, 2023
Nonalcoholic Fatty Liver Disease, Type 2 Diabetes Trial in Damanhur (Dapagliflozin 10mg Tab, Placebo)
Recruiting
- Nonalcoholic Fatty Liver Disease
- Type 2 Diabetes
- Dapagliflozin 10mg Tab
- Placebo
-
Damanhūr, Elbehairah, EgyptRehab Hussein Werida
Aug 11, 2022
NAFLD Trial (homocysteine (Hcy) lowering supplements)
Not yet recruiting
- NAFLD
- homocysteine (Hcy) lowering supplements
- (no location specified)
Jan 31, 2023
Hypercholesterolemia Trial (HSK31679 low dose, HSK31679 medium dose, HSK31679 high dose)
Not yet recruiting
- Hypercholesterolemia
- HSK31679 low dose
- +4 more
- (no location specified)
Mar 20, 2023
NAFLD, PCOS Trial in San Francisco (Bicalutamide 50 mg, Placebo)
Not yet recruiting
- NAFLD
- PCOS
- Bicalutamide 50 mg
- Placebo
-
San Francisco, CaliforniaUniversity of California San Francisco
Aug 4, 2023
Nonalcoholic Fatty Liver Disease (NAFLD) in Adults
Completed
- Non-Alcoholic Fatty Liver Disease
- Non Alcoholic Steatohepatitis
- non-applicable
-
Fort Sam Houston, TexasSan Antonio Military Medical Center
Mar 21, 2022
Nonalcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes (T2DM) Trial in Gainesville (Lanifibranor, Placebo)
Recruiting
- Nonalcoholic Fatty Liver Disease (NAFLD)
- Type 2 Diabetes (T2DM)
- Lanifibranor
- Placebo
-
Gainesville, FloridaUniversity of Florida
Sep 20, 2022
Nonalcoholic Fatty Liver Disease Trial in Jerusalem (Anti-human CCL24 mAb (CM-101) - Part One, Anti-human CCL24 mAb (CM-101) -
Completed
- Nonalcoholic Fatty Liver Disease
- Anti-human CCL24 monoclonal antibody (CM-101) - Part One
- +3 more
-
Jerusalem, IsraelHadassah University Hospital - Ein Kerem
Sep 13, 2023
Nonalcoholic Steatohepatitis
Recruiting
- Nonalcoholic Fatty Liver Disease (NAFLD)
- Nonalcoholic Steatohepatitis (NASH)
- Acoustic radiation force impulse (ARFI), magnetic resonance elastography (MRE)
-
Montréal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal
Nov 11, 2022
NAFLD in Adolescents and Young Adults With PCOS
Active, not recruiting
- Polycystic Ovary Syndrome
- +2 more
-
New York, New YorkColumbia University Medical Center
Jul 19, 2022
NAFLD Trial in Cairo (Lubiprostone 24Mcg Oral Cap)
Recruiting
- NAFLD
- Lubiprostone 24Mcg Oral Cap
-
Cairo, EgyptNational Hepatology and Tropical Medicine Research Institute
Mar 2, 2023
Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2
Completed
- Liver Disease
-
La Jolla, California
- +7 more
Feb 7, 2022
Weight Loss, NAFLD, Liver Diseases Trial in New York (YMCA class)
Active, not recruiting
- Weight Loss
- +2 more
- YMCA class
-
New York, New YorkWeill Cornell Medical College
Jan 26, 2022
Steatohepatitis, Nonalcoholic, Steatosis, Liver Diseases Trial in Curitiba (NUTRITIONAL EDUCATIONAL INTERVENTION IN FATTY LIVER
Active, not recruiting
- Steatohepatitis, Nonalcoholic
- +3 more
- NUTRITIONAL EDUCATIONAL INTERVENTION IN FATTY LIVER DISEASE NON-ALCOHOLIC (NAFLD).
-
Curitiba, Parana, BrazilHospital de Clínicas da Universidade Federal do Paraná
Jul 17, 2023
Nonalcoholic Fatty Liver Disease (NAFLD) Trial in Boston (Growth hormone, Placebo)
Completed
- Nonalcoholic Fatty Liver Disease (NAFLD)
- Growth hormone
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital
Nov 23, 2021
Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Patients
Completed
- Steatohepatitis, Nonalcoholic
- +4 more
-
Fort Sam Houston, TexasBrooke Army Medical Center
Mar 21, 2022
Observational Study About Patients Diagnosed With NAFLD
Recruiting
- Nonalcoholic Fatty Liver Disease
-
Changsha, Hunan, ChinaDepartment of Infectious Disease, Xiangya Hospital, Central Sout
Nov 25, 2022
Non-alcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic, NAFLD Trial (Efinopegdutide, Semaglutide, Placebo)
Not yet recruiting
- Non-alcoholic Fatty Liver Disease
- +4 more
- Efinopegdutide
- +2 more
- (no location specified)
May 17, 2023
Non-alcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic, NAFLD Trial in San Antonio (AZD7503 Intervention)
Active, not recruiting
- Non-alcoholic Fatty Liver Disease
- +5 more
- AZD7503 Intervention
-
San Antonio, TexasResearch Site
Jan 13, 2023
NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes
Active, not recruiting
- Nonalcoholic Fatty Liver
- +4 more
- Transient Elastography
-
Boston, MassachusettsJoslin Diabetes Center
Sep 16, 2022
Metabolic Pathology of Pediatric NAFLD
Recruiting
- Nonalcoholic Fatty Liver
- +2 more
- Cardiometabolic testing
-
Oklahoma City, OklahomaUniversity of Oklahoma Health Sciences Center
Jun 28, 2022
Accurate Point of Care Liver Disease Diagnostics
Recruiting
- NAFLD
- Nonalcoholic Fatty Liver
- Liverscope® exam
- +5 more
-
La Jolla, CaliforniaUniversity of California San Diego
Aug 8, 2023